Back to Search
LEWIS IACOVELLI, PHARMD, BCOP, CPP
PHARMD, BCOP, CPP
Oncology Pharmacist
NPI: 1699897736Individual
Specialties, Licenses & Credentials
Oncology PharmacistPrimary
Pharmacist — Oncology
Code: 1835X0200X
13198(NC)
Research & Publications (20)
Clinical management of EGFRI-associated dermatologic toxicities: pharmacy perspective.
PMID 18154216·Oncology (Williston Park)·2007
8-other
Regulation of group II metabotropic glutamate receptors by G protein-coupled receptor kinases: mGlu2 receptors are resistant to homologous desensitization.
PMID 19164443·Mol Pharmacol·2009
4-observational
Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care.
PMID 18447704·Pharmacotherapy·2008
8-other
Involvement of dopamine receptors and beta-arrestin in metamphetamine-induced inclusions formation in PC12 cells.
PMID 18266935·J Neurochem·2008
4-observational
Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis.
PMID 18082849·Neuropharmacology·2008
7-preclinical
Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease.
PMID 17986027·Eur J Neurosci·2007
8-other
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?
PMID 17653204·Mol Psychiatry·2007
7-preclinical
Metabotropic glutamate receptors: beyond the regulation of synaptic transmission.
PMID 17651904·Psychoneuroendocrinology·2007
6-review
Metabotropic glutamate receptors: new targets for the control of tumor growth?
PMID 17433452·Trends Pharmacol Sci·2007
7-preclinical
Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas.
PMID 16899734·J Neurosci·2006
7-preclinical
Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells.
PMID 16805831·J Neurochem·2006
7-preclinical
The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
PMID 16678160·Exp Neurol·2006
6-review
Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells.
PMID 15947794·Cell Death Differ·2005
7-preclinical
PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors.
PMID 15548648·J Neurosci·2004
7-preclinical
Analysis of differential modulatory activities of GRK2 and GRK4 on Galphaq-coupled receptor signaling.
PMID 15488187·Methods Enzymol·2004
8-other
Activation of Fas receptor is required for the increased formation of the disialoganglioside GD3 in cultured cerebellar granule cells committed to apoptotic death.
PMID 15207324·Neuroscience·2004
4-observational
Regulation of mGlu4 metabotropic glutamate receptor signaling by type-2 G-protein coupled receptor kinase (GRK2).
PMID 15102938·Mol Pharmacol·2004
8-other
Expression of OP4 (ORL1, NOP1) receptors in vascular endothelium.
PMID 14660000·Eur J Pharmacol·2003
7-preclinical
Presence of beta-arrestin in cellular inclusions in metamphetamine-treated PC12 cells.
PMID 14598068·Neurol Sci·2003
4-observational
Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins.
PMID 12857724·J Biol Chem·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
3.9(44)
- Address
- 501 N ELAM AVE, REGIONAL CANCER CENTER
GREENSBORO, NC 27403 - Phone
- (336) 832-0771
- Website
- conehealth.com
3.9(44)
See full reviewsQuick Facts
- NPI
- 1699897736
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile